iomeprol has been researched along with Critical Illness in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Critical Illness: A disease or state in which death is possible or imminent.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denz, C | 1 |
Siegel, L | 1 |
Lehmann, KJ | 1 |
Dagorn, JC | 1 |
Fiedler, F | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Incidence of Pancreatic Exocrine Insufficiency and the Benefits of Pancreatic Enzyme Supplementation in Critically Ill Adult Patients[NCT01753024] | 362 participants (Actual) | Observational [Patient Registry] | 2012-01-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for iomeprol and Critical Illness
Article | Year |
---|---|
Is hyperlipasemia in critically ill patients of clinical importance? An observational CT study.
Topics: Adult; Antigens, Neoplasm; Biomarkers, Tumor; Contrast Media; Critical Illness; Female; Humans; Inte | 2007 |